TABLE 1.
E2F1 transgenic line | 3-week-old mice
|
Embryos at E17.5
|
||
---|---|---|---|---|
Viabilityb | Observed/expected ratioc | Viability | Observed/expected ratio | |
TEF1-5 (Eμ-pp-E2F1) | 32/151 (F2 and F3) | 32/75 = 0.43 | 16/35 | 16/17 = 0.94 |
TEF1-21 (Eμ-pp-E2F1) | 2/57 (F1) | 2/28 = 0.07 | NDd | |
TEF1-43 (Eμ-pp-E2F1) | 1/26 (F1) | 1/13 = 0.08 | ND | |
TEF1-62 (Eμ-pp-E2F1) | 2/10 (F1) | 2/5 = 0.40 | ND | |
Actin-Cre;+/R26E2F1;R26E2F1;+/Actin-Cre | 30/181 | 30/45 = 0.67 | ND |
The mice were genotyped by PCR or Southern blot analysis of tail DNA. Viability of 3-week-old mice and of embryos at E17.5 were determined. Embryonic analysis on founder lines TEF1-21, TEF1-43, and TEF1-62 were not determined, since these transgenic lines could not be maintained. For heterozygous Actin-Cre; R26E2F1;+ crosses, embryonic survival data were not determined.
Number of mice that survived to 3 weeks of age (or E17.5)/total number of mice (or embryos).
Observed/expected ratio is the ratio of the observed number of mice (or embryos) that survived to the number of mice (or embryos) expected to survive.
ND, not determined.